Loading quotes...
Forecast
| Buy |
7 |
| Hold |
1 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | -3.5k | 96.67% |
| Net profit | -1.16m | 73.89% |
| EBITDA | -1.56m | 64.10% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €634.77k |
Number of shares | 427.08k |
52-week high/low | €22.36 - €1.31 |
| Dividends | No |
Beta | 1.70 |
P/E ratio | -0.09 |
PEG ratio | 0.00 |
P/B ratio | 0.40 |
P/S ratio | 0.00 |
Company profile
| Name | Matinas BioPharma |
| CEO | Jerome D. Jabbour |
| Employees | 2 |
